Computational phenotypes for patients with opioid-related disorders presenting to the emergency department. [PDF]
PLoS One, 2023 Objective: We aimed to discover computationally-derived phenotypes of opioid-related patient presentations to the ED via clinical notes and structured electronic health record (EHR) data.
Taylor RA +9 more
europepmc +9 more sources
Correction: Computational phenotypes for patients with opioid-related disorders presenting to the emergency department. [PDF]
PLoS One[This corrects the article DOI: 10.1371/journal.pone.0291572.].
Taylor RA +9 more
europepmc +5 more sources
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials. [PDF]
PLoS One, 2022 Introduction Several pharmacotherapeutic interventions are available for maintenance treatment for opioid-related disorders. However, previous meta-analyses have been limited to pairwise comparisons of these interventions, and their efficacy relative to ...
Lim J +3 more
europepmc +5 more sources
Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study. [PDF]
Int J Drug Policy, 2022 AbstractBackgroundThe use of opioids is increasing globally, but data from low- and middle-income countries on opioid-related mental and behavioural disorders (hereafter referred to as opioid-related disorders) are scarce. This study examines the incidence of opioid-related disorders, opioid agonist use, and excess mortality among persons with opioid ...
Tlali M +9 more
europepmc +8 more sources
The Effects of Probiotic Supplementation on Opioid-Related Disorder in Patients under Methadone Maintenance Treatment Programs [PDF]
International Journal of Clinical Practice, 2022 Introduction. Patients under methadone maintenance treatment programs (MMTPs) are susceptible to numerous complications (e.g., mental and metabolic disorders). This study evaluated the effects of probiotics on clinical symptoms, biomarkers of oxidative stress, inflammation, insulin resistance, and serum lipid content in patients receiving MMTPs ...
Nader Molavi +10 more
openalex +3 more sources
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders [PDF]
JAMA psychiatry, 2020 Key Points Question Does prescription opioid medication have a potentially causal role in the risk for depression and anxiety disorder? Findings In this 2-sample mendelian randomization study using genetic instruments for common pain medications, the ...
Daniel B. Rosoff +2 more
openalex +2 more sources
State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees [PDF]
JAMA Health Forum, 2023 ImportanceThe opioid crisis disproportionately affects Medicaid enrollees, yet little systematic evidence exists regarding how prevalence of and health care utilization for opioid use disorder (OUD) vary across geographical areas.ObjectivesTo characterize state- and county-level variation in claims-based prevalence of OUD and rates of medication ...
Stephan Lindner +4 more
openalex +3 more sources
Pain Medicine, 2020 OBJECTIVE Opioid use during pregnancy has increased in recent years, parallel with the opioid epidemic in the general population. Opioids are commonly used as an analgesic for pain crisis, a hallmark symptom of sickle cell disease (SCD).
F. Darlington +13 more
semanticscholar +4 more sources
Comorbidity of opioid-related and anxiety-related symptoms and disorders.
Current Opinion in Psychology, 2019 Opioid use disorder and anxiety disorders co-occur at strikingly high rates, and this comorbidity is marked by a more severe clinical presentation and poorer prognosis for treatment. Given the substantial morbidity and mortality associated with these two disorders, it is imperative to understand factors related to the high rates of co-occurrence in ...
Kirsten J. Langdon +2 more
semanticscholar +4 more sources
A Systematic Review of Opioid Use Disorder and Related Biomarkers
Frontiers in Psychiatry, 2021 The objective of this systematic review is to examine the relationship between opioid use disorder (OUD) and its related biomarkers, as well as the effects of pharmacotherapy for OUD on biomarkers.
Bianca M. Bryant, Ellen Eaton, Li Li
doaj +2 more sources